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Abstract
Background—Magnetic fields (MF) from AC electricity are a Possible Human Carcinogen, 
based on limited epidemiologic evidence from exposures far below occupational health limits.
Methods—To help formulate government guidance on occupational MF, the cancer cases 
prevented and the monetary benefits accruing to society by reducing workplace exposures were 
determined. Life-table methods produced Disability Adjusted Life Years, which were converted to 
monetary values.
Results—Adjusted for probabilities of causality, the expected increase in a worker’s disability-
free life are 0.04 year (2 weeks) from a 1 microtesla (μT) MF reduction in average worklife 
exposure, which is equivalent to $5,100/worker/μT in year 2010 U.S. dollars (95% confidence 
interval $1,000–$9,000/worker/μT). Where nine electrosteel workers had 13.8 μT exposures, for 
example, moving them to ambient MFs would provide $600,000 in benefits to society (uncertainty 
interval $0–$1,000,000).
Conclusions—When combined with the costs of controls, this analysis provides guidance for 
precautionary recommendations for managing occupational MF exposures.
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INTRODUCTION
After electric and magnetic fields (EMF) at extremely low frequencies (ELF = 3–3,000 Hz) 
were declared a Possible Human Carcinogen [Kriteriegruppen for Fysickliska Riskfactorer, 
1995; Portier and Wolfe, 1998; NRPB, 2001; IARC, 2002; Neutra et al., 2002; WHO, 2007], 
public health agencies faced difficult decisions on managing high-voltage transmission lines 
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and other sources of high EMF in homes, schools, and workplaces. There has been “limited 
epidemiologic evidence” of associations of ELF magnetic fields (MF) with childhood 
leukemia [Kriteriegruppen for Fysickliska Riskfactorer, 1995; Portier and Wolfe, 1998; 
NRPB, 2001; Neutra et al., 2002; IARC, 2002; WHO, 2007] and adult cancers [Portier and 
Wolfe, 1998; Neutra et al., 2002], but few toxicological and mechanistic studies provided 
support for a causal association [WHO, 2007]. Reviews of ELF-MF health risks have also 
noted epidemiologic associations with neurodegenerative diseases [Neutra et al., 2002; 
Kheifets et al., 2008a] and miscarriages [Neutra et al., 2002].
Most standard-setting organizations base their EMF exposure limits on acute neurological 
effects, while the cancer evidence is not generally considered sufficient to reduce exposures 
[IEEE, 2002; ACGIH, 2006; ICNIRP, 2010]. Consequently, MF exposure limits are more 
than a thousand times higher than the magnitudes associated with the cancer risks observed 
in epidemiologic studies, leaving millions of workers exposed to MF in this large gray area 
where the public health consequences are unclear.
For example, the National Institute for Occupational Safety and Health (NIOSH) has 
conducted three Health Hazard Evaluations (HHE) in which MF exposures fell in this 
ambiguous realm (Table I). In one study of an electro-steel furnace [Moss and Booher, 
1994], the maximum magnetic field exposures of the six operators ranged from 80 to 148 
μT, an order of magnitude below the threshold limit value (TLV) of 1,000 μT for 60 Hz 
magnetic fields [ACGIH, 2006]. However, the time-weighted average (TWA) magnetic 
fields were 11–17 μT, an order of magnitude above 0.2–1.0 μT, where occupational 
epidemiologic studies have reported elevated cancer risks [Floderus et al., 1993; Savitz and 
Loomis, 1995; Kheifets et al., 1999]. The three HHE reports suggested reductions in MF 
exposures at these workplaces, but the rationales for these interventions varied (Table I) 
[Moss and Booher, 1994; Malkin and Moss, 1995; Moss and Ragab, 1995].
Evidence-based approaches to managing workplace magnetic fields are clearly needed. The 
World Health Organization recommends: “Providing the health, social, and economic 
benefits of electric power are not compromised, implementing very low-cost precautionary 
procedures to reduce exposures is reasonable and warranted” [WHO, 2007]. For homes and 
schools, cost-effective precautionary measures have been identified by cost-benefit analyses 
of the childhood leukemia risks [Swedish National Board for Occupational Safety Health et 
al., 1995; California EMF Program, 2002a; von Winterfeldt et al., 2004; WHO, 2007].
In order to extend this precautionary approach to workplaces, we conducted a risk 
assessment on MF carcinogenesis and calculated the disease burden from magnetic field 
exposures, expressed as Disability-adjusted Life Years (DALY) lost. Because DALYs 
measure pain and suffering from the disease plus potential losses in productivity resulting 
from premature death, the monetary equivalent of intervention benefits equals the change in 
DALYs multiplied by a suitable value for a disability-free year of life [Kassouf et al., 2005; 
Forbes et al., 2006]. Under the utilitarian approach to public health policy [Swedish National 
Board for Occupational Safety Health et al., 1995; California EMF Program, 2002a; von 
Winterfeldt et al., 2004], an intervention is in the public interest when the potential reduction 
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in DALYs or gain in their monetary equivalent is greater than the associated intervention 
costs.
Another important component in practical precautionary recommendations is setting an 
exposure level below which health risks are minimal so mitigation efforts would not be 
justified. In setting this “precautionary level” (PL) for occupational MF, the most useful risk 
metrics for an exposure are (1) DALYs, a measure of the expected personal and economic 
costs, and (2) the cancer incident rate, a public health measure which NIOSH uses to 
establish recommended exposure limits [Reed et al., 1994]. After policy makers set de 
minimis levels for one of these risk metrics, a MF precautionary limit can be derived from 
the plots in this article. Our intention with this risk assessment is not to recommend 
mandatory exposure limits, but to help determine which MF exposures might reasonably be 
reduced under the precautionary principle.
With a determination of the interventions that are cost-effective, well-established strategies 
for managing workplace hazards can then be recommended for occupational MF [Bolte and 
Pruppers, 2006; Patterson and Hitchcock, 2008].
METHODS
Our methods for calculating DALYs and the monetary costs of a workplace MF exposure 
are outlined in Figure 1. The risk assessment concludes with uncertainty and sensitivity 
analyses of the calculated metrics. Our rationale for these procedures is given below, and the 
mathematical details accompany this article as Supplemental Online Material [See Section 
A,B,C,D,E,F in the Supplemental Information].
Disease Selection
To include a disease in this risk assessment, we required 1) a finding by a governmental or 
international authority that occupational ELF magnetic fields are a possible risk factor 
(equivalent to IARC’s Group IIB carcinogens); and 2) a significant dose–response with 
magnetic field measurements found by pooling data from multiple workplace studies. Brain 
cancer and leukemia fulfill these two criteria. The California EMF Project conducted by 
California’s health department found MF to be a Possible Human Carcinogen (Group IIB), 
based on epidemiologic associations with adult brain cancer and leukemia [Neutra et al., 
2002]. Furthermore, limited epidemiologic evidence for leukemia in workplace studies was 
a factor in the Group IIB evaluations given by the Swedish Criteria Group [Kriteriegruppen 
for Fysickliska Riskfactorer, 1995] and a working group convened by the National Institute 
of Environmental Health Sciences [Portier and Wolfe, 1998]. Dose–response relationships 
were found for these two cancers in a comparative analysis [Kheifets et al., 1999] of four 
electric utility studies with full-shift personal MF monitoring [Sahl et al., 1993; Theriault et 
al., 1994; Savitz and Loomis, 1995; Miller et al., 1996].
Dose–Response Relationships
Kheifets et al. [1999] calculated dose–response (DR) relationships for brain cancer and 
leukemia with an exponential model:
Bowman et al. Page 3
Am J Ind Med. Author manuscript; available in PMC 2015 December 22.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
(1)
where C is the worker’s cumulative MF exposure in μT-yr, and RR′ ≡ exp(10β) is the DR 
slope expressed as a multiplier of the relative risk for each 10 μT-year increase in exposure 
[See Section A in the Supplemental Information]. Their results (Table II and Fig. 2) were 
significant for brain cancer (P = 0.031) and marginally significant for leukemia (P = 0.050).
NIOSH Exposure Scenario for Risk Assessments
NIOSH risk assessments calculate excess lifetime risk by specifying a constant exposure 
from starting work at age 20 until retiring up to 45 years later [Reed et al., 1994]. While 
meaningful over the range of cumulative exposures observed in the electric utility studies 
(Fig. 2), the exponential function (Eq. 1) under the NIOSH exposure scenario gives 
unrealistic RRs of over 100 for C > 45 μT-years, which would result from 45 years of work 
at the TWA MFs greater than 1 μT observed by NIOSH Health Hazard Evaluations (Table 
I).
This breakdown in the exponential model at higher cumulative exposures partly reflects the 
low duration of employment in the utility cohorts (means = 18.5–24.9 years) [Kheifets et al., 
1999]. This employment in the study cohorts is clearly less than the workers’ total work 
careers since the median age of cancer diagnosis or death ranged from 58 to 64 years 
[Kheifets et al., 1999], suggesting median work careers among cases of nearly 40 years. 
Therefore, the cumulative MF calculated from the utility data possibly underestimates the 
workers’ true exposures including those from previous employment, resulting in over-
estimates of the cancer risks from the exponential model.
Kheifets et al. [1999] used the exponential model for mathematical convenience with 
logistic regression, but a linear model is usually preferable for carcinogenesis. We therefore 
selected a linear model RR(C) = a + b C to represent the higher cumulative exposures. The 
slope and intercept of the linear model were chosen to match the exponential model and its 
slope at the relative risk in the highest exposure category from the electric utility studies 
(Table II and Fig. 2) [See Section A in the Supplemental Information].
Lifetime Cancer Incidence and Mortality
The life-table method was then used to calculate cause-specific lifetime mortality and 
incidence from a given MF exposure [BEIR, 1988]. Data for this calculation included 
mortality rates for the U.S. population [Arias, 2006], and cancer incidence and mortality 
rates from National Center for Health Statistics (NCHS) [SEER, 2006a,b].
We made two modifications to the life-table formulas for calculating excess mortality and 
cancer incidence among workers [BEIR, 1988]. First, all-cause mortality rates were adjusted 
for excess deaths with the MF exposure resulting from two diseases (brain cancer and 
leukemia) [See Section B in the Supplemental Information]. Second, rates for cancer 
mortality and incidence were adjusted for the cancers predicted to result from occupational 
MF exposures in the U.S. population [See Section B in the Supplemental Information]. For 
our population-based calculations, the best available occupational MF data are 
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measurements from a 1,000-person randomized survey in the U.S. [Zaffanella, 1998]. From 
published descriptive statistics on the 525 working subjects, we derived a log-normal 
distribution of U.S. occupational MF exposures, which were used to adjust the reported 
cancer mortality and incidence rates to “non-exposed” levels [See Section B in the 
Supplemental Information].
Life-table methods were used to calculate lifetime cancer incidence and mortality with and 
without MF exposure. To obtain DALYs, we also calculated the excess incidence for 
leukemia subtypes [See Section B in the Supplemental Information].
Disability-Adjusted Life Years (DALY)
Developed by Murray and Lopez [1996a], the DALY combines measurements of premature 
death and disability to quantify the disease burden to human life. DALY extends the concept 
of potential years of life lost (YLL) resulting from premature death to include equivalent 
“years lived with disability” (YLD) by virtue of being in states of ill health. For a typical 
disease or health condition, DALYs are the sum of YLL and YLD. Therefore, a disease 
which causes great disability during and after treatment has a greater DALY than a disease 
with the same effect on life expectancy but little disability.
In order to calculate the DALY in this case, published age-specific life-expectancies [Arias, 
2006] were multiplied by the excess cancer mortality for a MF exposure, B, from both 
cancers and summed across all ages from 20 up to 90 years of age to obtain the YLL(B) 
[See Section C in the Supplemental Information]. Next, YLD was calculated according to a 
“burden of disease” study from Victoria, Australia Victoria [Victoria Public Health Group, 
1999ab]. The Victoria study is largely based on the methods of the Global Burden of 
Disease Study at the World Health Organization (WHO) [Murray and Lopez, 1996a]. To 
predict the lifetime YLD from a given MF exposure, age-dependent excess incidences were 
calculated by the life-table method for brain cancer and the five leukemia sub-types and then 
inserted into the YLD formulas from the Victorian study [Victoria Public Health Group, 
1999a]. The resulting YLD(B) is simply added to YLL to get the DALY per person exposed 
to a TWA magnetic field B: DALY(B) = YLL(B) + YLD(B).
Discounted DALYs
Health economists often place a positive discount rate on future health effects, based on the 
opportunity costs of health investment, the diminishing marginal utility of life, and people’s 
preference to have good health earlier rather than later in life [Weinstein, 1990; Olsen, 1993; 
Murray and Lopez, 1996a,b]. A 3% discount rate was used for cost effectiveness analyses as 
recommended by a multi-disciplinary “consensus panel” convened by the US Public Health 
Service [Lipscomb et al., 1996]. The discounted summed DALYs for brain cancer and 
leukemia are the average disease burden attributable to a MF exposure level. The difference 
in the discounted DALYs before and after the intervention is the predicted effectiveness of 
the MF reduction.
DALYs are often age weighted so as to provide more prominence to the young and mid 
adult life in terms of social responsibilities and productivity [Murray and Lopez, 1996b]. 
Since subjects in this study are predominantly of working age, age weighting according to 
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this Human Capital approach would imply valuing their productivity differently. As the 
study is not controlling for other related factors like education, occupation, and consumption 
pattern of individuals, we refrain from weighting DALYs according to age.
Monetary Benefits From the Reduction of Magnetic Field Exposures
Most economists and policy analysts agree on the general principle that the life-saving 
benefits from a preventive activity should be compared to its costs. DALYs measure health 
burden, while preventive interventions are compared on the basis of their cost-effectiveness 
($/DALY) ratios, the one with the lowest being the most economically effective. Although 
the costs of MF reduction measures are not known, the DALYs from the cancer burden are 
converted to monetary values so that the benefits accruing from interventions can be easily 
compared to costs when available.
Conversion of DALYs to immediate monetary terms by multiplying with the value of a year 
of life is not uncommon. This study uses a conceptually similar approach of equating the 
value of one DALY to the value of a statistical life year (VSLY). Therefore the monetary 
cancer burden, b$(B), from a magnetic field exposure, B, is:
(2)
VSLY in turn can be derived from the value of a statistical life (VSL) divided by the life 
expectancy conditional on surviving the current mortality risks.
For the VSLY and consequently the value of the DALY, the value of $100,000 is used 
which the U.S. Food and Drug Administration placed on each year of life saved by nutrition 
labeling in 1999 [FDA, 1999]. Similar values for a life-year have been suggested by other 
investigators [Zarkin et al., 1993; Tolley et al., 1994; Cutler and Richardson, 1997]. As the 
DALYs are already discounted to their present value, monetary benefits are not further 
discounted. However, the monetary benefits obtained in 1999 dollars were then converted to 
2010 dollars adjusting for the rate of change in inflation as reflected in the consumer price 
index [Bureau of Labor Statistics, 2011].
Finally, the discounted DALYs (as a fraction of a 45 year work life) and the incidence rates 
for brain cancer plus leukemia were plotted against TWA magnetic fields in order to derive 
candidate precautionary limits (PL) on exposure reduction efforts. As a demonstration of the 
PL concept, several de minimis values of risk were selected arbitrarily, and the 
corresponding PL calculated. In these demonstrations, the only de minimis risk value with an 
occupational health justification is the incidence rate of 1 cancer per 1,000 exposed, which 
NIOSH and OSHA use for setting exposure limits [Reed et al., 1994].
Decision Analysis
After the conventional risk assessment is complete, uncertainty in the underlying causal 
association is incorporated through decision analysis [DeKay et al., 2002]. In conventional 
cost-benefit analyses, an intervention is justified if the discounted dollar value of the future 
lives saved is greater than the cost of the controls (c), or in other words, the net benefits to 
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society are greater than zero. In order to incorporate uncertainty about the MF-cancer 
association into this cost-benefit analysis, decision analysis assumes a probability Pc that the 
reported DR is a causal relationship. Then a decision tree (Fig. 3) can be constructed on the 
principle that costs of an intervention should be less than or equal to the predicted costs of 
averted cancer deaths. The resulting decision rule (Fig. 3) can then be expressed in terms of 
the expected value of the net benefits from a reduced cancer burden:
(3)
where the TWA magnetic fields B are estimated before and after the proposed intervention.
In setting a precautionary limit, the probability of causation is treated differently because a 
policy decision justifies interventions, rather than a cost-benefit analysis. For a chosen risk 
metric z (i.e., the cancer incidence or the economic burden from a TWA exposure B), the 
decision rule for intervening can be written in terms of its expected value under the scientific 
uncertainty:
(4)
where zno causation = 0 for any MF exposure, and the value of zpolicy (e.g., 1 in 1,000 cancer 
incidence) is chosen by policy makers. A precautionary limit on Bbefore can then be derived 
from Pc zcausal(Bprecaution) = zpolicy.
Probability of Causality
To make this decision analysis a practical tool for decision makers, an objective method is 
needed for evaluating the probability Pc that reported epidemiologic associations are causal 
relationships. The California EMF Project performed a “qualitative Bayesian analysis” 
which provides estimates of Pc, based on the same scientific literature reviewed by IARC 
and the other governmental risk assessments [Neutra et al., 2002].
In this approach, the attributes of the epidemiologic and toxicology evidence used in 
conventional risk evaluations (strength of association, bias, confounding, consistency, 
extrapolation from animals to humans, etc.) were evaluated by three scientists from the 
California health department as to their support for the causal and “no effect” (null) 
hypotheses. Motivated by Bayes Theorem, the evaluation starts with a subjective evaluation 
of the probability “prior” to any research that EMF “is capable of altering the risk of one or 
more cancers or other diseases” [Neutra et al., 2002, p. 63]. If each piece of evidence was 
better explained by the causal hypothesis than the null hypothesis, then the probability 
increased; if not, it decreased [Neutra et al., 2002]. After the reviewers evaluated all 
evidence, they arrived at their “posterior probability” that the EMF exposure caused the 
disease. To be more understandable to the general public, the results were reported as the 
“degree of certainty” on a scale of 0–100 that “EMFs increase disease risks to some degree” 
[Neutra et al., 2002], which is clearly equivalent to 100 times the Bayesian posterior 
probability Pc used in decision theory [DeKay et al., 2002].
The three reviewers from the California health department assigned degrees of certainty of 
80, 50, and 60 to adult brain cancers with “margins of uncertainty”—with a low of 30 and a 
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high of 100, [Neutra et al., 2002, p. 165]—giving an average score of 63. For adult 
leukemia, the results were 80, 55, and 40 with uncertainty margins from 25 to 95 [Neutra et 
al., 2002, p. 120], which averages 58. Rounding off to one decimal place, the mean posterior 
probabilities for adult leukemia and brain cancer are both Pc ≈ 0.6 with an uncertainty from 
0.2 to 1.0.
Uncertainty Analysis
For our uncertainty analysis, we first identified all sources of variability and error in our risk 
metrics and when possible, quantified the uncertainty of the input variables for the risk 
calculations (Table III). The quantified uncertainties fall into three groups: the DR 
parameters and the MF exposure distribution whose statistical properties can be rigorously 
characterized, sources of bias for which the data is suggestive, and the parameters for which 
we have only a range of possible values (the monetary value of the DALY, the discount rate, 
and the posterior probability) [See Section D in the Supplemental Information]. For the DR 
and exposure distribution parameters, our uncertainty analysis consisted of a rigorous 
propagation of errors, which resulted in 95% confidence limits (95% CL) and P-values from 
one-tailed hypothesis tests for the metrics [See Section E in the Supplemental Information].
For the more poorly characterized parameters, our uncertainty analysis also used the 
propagation of error formulas but with approximate biases and standard errors derived from 
the range of possible values [See Section D in the Supplemental Information]. The 95% 
probability limits around a bias-adjusted mean derived from these more approximate error 
estimates are called uncertainty limits (UL) [Phillips et al., 1997; See Section E in the 
Supplemental Information]. When a calculated uncertainty limit exceeds the null-hypothesis 
value, the convention is to report the null-hypothesis value as the uncertainty limit [Phillips 
et al., 1997].
For the precautionary levels, a similar uncertainty analysis was conducted [See Section F in 
the Supplemental Information].
RESULTS
Table IV presents the years of life lost (YLL), years lost to disability (YLD), the expected 
values for the total DALY = Pc DALY(B), and the lifetime economic burden (discounted 
and undiscounted) for a logarithmic series of magnetic field levels. The regression 
coefficient for the expected economic burden with discounting versus the magnetic field is 
$5,100 per μT per worker exposed (Table V), which also approximates the benefit from a 1 
μT reduction in a worker’s MF exposure. Considering random errors in the dose–response 
estimate, these effects are significant (95% CL = $1,000–$9,000/worker/μT; P < 0.03). 
When the posterior probability and all other quantified sources of uncertainty (Table III) are 
included in the sensitivity analysis [See Section E in the Supplemental Information], the 
uncertainty limits range from $0 (no effect) to $12,000, in the absence of chemical 
exposures (Table V). When the reported effects of mercury, lead, arsenic, solvents, 
pesticides, or herbicides are present, the upper uncertainty limit increases by $3,000 per 
chemical (Table V).
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Examining the YLL and YLD results more closely (Table V), the years lost to disability 
from cancers attributable to workplace MF are a small fraction of the years of life lost (5% 
for brain cancer and 12% for leukemia for the discounted values). This relationship is due to 
the increasing excess in cancer incidence with age due to a constant workplace MF exposure 
[See Section B in the Supplemental Information, Table S-I]. With these cancers, the excess 
incidence peaks with workers in their 70s when cancer is more often fatal than disabling. 
The same result was observed with leukemia due to workplace benzene [Driscoll et al., 
2005]. Between the two cancers, the brain cancer YLL is +7% greater than the leukemia 
YLL, which is not significant (Fig. 4). Discounting reduces the YLL substantially (73% for 
brain cancer and 75% for leukemia), which is reflected in a similar diminution of the 
DALYs. All metrics are very close to linear functions of the TWA magnetic fields (R2 > 
0.99 in all cases). Since deviations from linearity in YLL are well within the 95% 
confidence limits (Fig. 4), economic burdens and their uncertainties can be calculated for 
specific TWA exposures from the slopes in Table V without sacrificing precision.
Similarly, precautionary limits (PL) are useful for managing workplace MF because lower 
TWAs are expected to have minimal risks and/or economic burdens (as defined by 
stakeholders). A de minimis cancer risk of 1 per 1,000 gives a PL of 0.28 μT (95% CL = 
0.14–9.3 μT; P = 0.02; UL = 0.17–∞ μT) with the uncertainty limits going to 0.14–∞ μT in 
the presence of mercury [See Section E in the Supplemental Information]. Figure 5 shows 
other possible PLs ranging from 0.16 to 0.53 μT that can be derived from alternative 
minimal values for the cancer risk or the discounted cancer burden, but they all have wide 
over-lapping confidence intervals.
These findings can be applied to the examples in Table I. In all three workplaces, the TWA 
exposures are above the 0.28 μT PL, so quantitative evaluations of interventions are justified 
by the possible cancer risks. As shown in Figure 6 and Table VI, the benefits of 
interventions with the electrosteel furnace can be calculated by taking the difference in the 
expected burden before and after an intervention. If the furnace’s control room were moved 
away from its transformer to a location with the ambient TWA ≈ 0.1 μT, exposures would 
be reduced by 13.6 μT, so the expectation for the discounted lifetime benefits = 13.6 μT × 
$5,100 per μT = $69,000 approximately per worker exposed. For all nine control room 
operators affected by this exposure reduction, the expected lifetime benefits of the 
intervention would be 9 × $69,000 = $600,000 (rounded off to one significant figure). Since 
the HHE report mentions no exposures to the five chemicals with MF interactions (Table 
IV), the uncertainty limits on the benefits are $0–$1,000,000. Under a utilitarian approach to 
public health, moving the control room would be in the public interest if the moving costs 
were less than the total benefits for all exposed workers. The expected workforce benefits 
for the interventions proposed by the other two Health Hazard Evaluations are $30,000 ($0–
$60,000 uncertainty) for the tax office and $50,000 ($0–$100,000 uncertainty) for the TV 
station (Table VI).
DISCUSSION
This work attempts to quantify the health benefits from reducing exposures to occupational 
ELF magnetic fields, which some have been classified as a Possible Human Carcinogen 
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[Kriteriegruppen for Fysickliska Riskfactorer, 1995; Portier and Wolfe, 1998; Neutra et al., 
2002].
These findings are based on the current state of etiologic inference: statistically significant 
but controversial risks for leukemia and brain cancer at exposures well below the present 
exposure limits derived from proven biological effects. The uncertainty, arising in part from 
exposure assessment errors, encompasses a wide range of possible risk whose upper end 
would have very substantial public health impact. A similar challenge exists today with the 
radio-frequency EMF from cell-phones, which were recently declared a Possible Human 
Carcinogen [Baan et al., 2011]. Since the possible carcinogen rating does not meet most 
standards for legally binding regulations, we undertook this risk assessment as guidance for 
public health agencies to identify cost-effective recommendations for avoiding ELF-MF 
exposures under the Precautionary Principle [Resnik, 2003; Tickner et al., 2003].
Many steps in our approach (Fig. 1) are established methods in occupational health and risk 
assessment: evaluating a worker’s lifetime cancer risks from TWA measurements on a 
single shift [Reed et al., 1994], using life-table methods, quantifying disease burden with 
DALYs, discounting the burden, and incorporating uncertainty with decision theory. 
Nonetheless, these steps involve assumptions and inherent sources of uncertainty, which are 
summarized in Table III. This discussion focuses on the steps in our risk assessment that 
involved more discretion: disease selection, the dose–response relationships, the monetary 
costs of a DALY, the posterior probability for causation, and our underlying premise that a 
cost-benefit analysis can provide useful guidance for pre-cautionary measures.
In choosing data for our quantitative risk assessment, the Precautionary Principle is that 
scientific confirmation may be too strict a requirement for precautionary public health 
interventions. Public health agencies must be concerned about false negatives (type II errors) 
delaying interventions that might prevent diseases and deaths. In our approach, science-
based public health policies may recommend interventions without full confirmation of the 
risks when their expected benefits credibly outweigh their costs.
To develop public health recommendations in the absence of scientific certainty, cost-
benefit analyses combined with decision analysis are a rational approach as long as the 
underlying evidence meets some standard of credibility [Resnik, 2003]. Our approach to 
managing EMF’s possible occupational hazards is consistent with some formulations of the 
Precautionary Principle, although that philosophy is not explicitly incorporated into the U.S. 
occupational health law [Resnik, 2003; Tickner et al., 2003; Graham, 2004].
To assure credible scientific evidence of possible harm, we decided on two criteria for 
disease selection in the Methods Section, but other choices are possible. For example, the 
finding of Possible Human Carcinogen (or its equivalent for non-cancerous outcomes) could 
be required from the most recent risk evaluation. The most recent evaluation is WHO’s 
criteria monograph, which decided occupational EMF is not a possible carcinogen [WHO, 
2007]. However, a public health policy based on the most recent report would be liable to 
change from year to year. Furthermore, a single report, even from a prestigious agency like 
WHO, is liable to errors. For example, WHO’s monograph cites only the null associations 
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from a Swedish brain cancer study [WHO, 2007, p. 294], ignoring relative risks as large as 
3.91 (95% CI 1.26–12.15) for exposures to both lead and TWA MF above 0.2 μT [Navas-
Acien et al., 2002]. Since the overall literature on occupational EMF is clearly split between 
seeing no cancer association or a small risk of brain cancer and leukemia [Kheifets et al., 
1999], our requirement of a single credible risk evaluation is a prudent approach to disease 
selection.
In the other direction, a disease could be included in the risk assessment if a significant 
dose–response is found by one well-done study, rather than by a meta-analysis of multiple 
studies. However, occupational EMF epidemiology has produced a bewildering mixture of 
significant and non-significant DRs [Kheifets et al., 2008a], which is expected from the 
Berkson errors created by job-exposure matrices [Thomas et al., 1993]. Therefore, 
appropriate meta-analytic modeling of the primary data from several high-quality studies 
appears to be the most reliable means of determining whether an EMF dose–response (or its 
absence) is due to chance.
Our risk and burden estimates would be greater if we had included higher prevalence 
diseases such as neurodegenerative diseases, and miscarriages that have been occasionally 
associated with magnetic fields [Lee et al., 2002; Park et al., 2005]. We rejected that 
approach because the absence of comparative epidemiologic studies for these diseases 
would give their dose–response slopes with very large confidence intervals, making 
decisions from the resulting DALYs even more uncertain [NRC, 2009]. On the other hand, 
MF risks would appear to be zero if the selection criteria were “sufficient, reliable evidence 
to conclude that long-term exposures … are adverse to human health or cause a disease” 
plus a “confirmed mechanism that would provide a firm basis to predict adverse effects,” as 
the Institute of Electrical and Electronic Engineers requires for its ELF-EMF exposure limits 
[IEEE, 2002]. We rejected this option for our precautionary risk assessment because it 
rejects a priori any evaluation of the possible cancer risks reported by the epidemiologic 
studies.
In selecting data on the dose–response, we chose the comparative analysis of four electric 
utility studies [Kheifets et al., 1999] because it provided the significant DR slopes required 
for a quantitative risk assessment. However, this study omits many high-quality studies of 
brain cancer and leukemia, both positive [Floderus et al., 1993; Hakansson et al., 2002] and 
negative [Johansen et al., 2007; Sorahan et al., 2001]. These newer studies were included in 
a recent meta-analysis [Kheifets et al., 2008b], which again reported elevated risks but now 
with no significant dose–response for the two cancers. However, this degraded significance 
could be due to the meta-analysis using only the published risks from diverse exposure 
categories for its dose–response calculations, which can lead to exposure misclassification 
and bias towards the null—a defect avoided by a comparative study of the primary data. 
Furthermore, Kheifets et al. [2008b] omitted the elevated brain cancer risks from combined 
chemical and MF exposures [Navas-Acien et al., 2002] as well as elevated leukemia risks 
from a combination of occupational and residential MFs in a Swedish cohort living along 
high-voltage transmission lines [Feychting et al., 1997]. Therefore, the comparative analysis 
[Kheifets et al., 1999] appears to be the best data available for our quantitative risk 
assessment.
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Another issue is the choice of an effectiveness measure that combines information on both 
morbidity and mortality. The U.S. Office of Management and Budget (OMB) prefers 
QALYs, although it does mention DALYs [Brown et al., 2001]. We chose DALYs primarily 
because they were used by WHO’s global burden of occupational disease study [Nelson et 
al., 2005], allowing us to later compare the impact of MFs with other occupational 
carcinogens.
An alternative method for measuring the economic burden of disease is the “cost of illness 
method,” which computes morbidity and mortality costs along with direct costs (largely 
medical expenditure). While DALYS incorporate the former, the latter remains unattended. 
A 2001 burden of illness study estimated the direct costs of all cancer-related cases to be 
$96.1 billion for 1990 [Brown et al., 2001]. From 1963 to 1995, cancer-related direct costs 
in the U.S. have held stable at less than 5% of overall health care expenditures and are 
estimated to average $35,418 per person [Goldman et al., 2003]. This measure of cancer 
costs per DALY underestimates the true economic burden as it does not account for the 
medical costs associated with treatment of the diseases and the productivity losses 
associated with replacement of the workforce.
The risk evaluation by the California EMF Program [Neutra et al., 2002] that we used for 
the posterior probabilities has been heavily criticized [California EMF Program, 2002b; von 
Winterfeldt et al., 2004]. Since California’s pioneering effort at Bayesian risk evaluation is 
the only existing effort to systematically quantify EMF’s probability of causality, its 
findings are essential if possible interventions are to be evaluated with decision theory. With 
the sharp bifurcation of opinion within the scientific community on whether EMF causes 
cancer [Neutra et al., 2002; Blackman et al., 2007; WHO, 2007], a naïve application of 
decision theory would average just the two branches of the decision tree (Fig. 4), which is 
equivalent to a prior probability of 0.5. In this light, the California review’s posterior 
probability of 0.6 represents a small, cautious upward adjustment, which is a reasonable 
position for a public health agency. Nonetheless, our risk estimates would be more reliable if 
the Bayesian risk evaluation method used by the California EMF Project were repeated by 
another organization with an up-to-date review of ELF-MF research.
The precautionary limits are based on de minimis values for the cancer risk and economic 
burden (Fig. 5) that are somewhat arbitrary with the exception of the 1:1,000 disease risk 
used by NIOSH to establish Recommend Exposure Limits (RELs) for occupational hazards 
[Reed et al., 1994]. However, RELs are recommended to OSHA as not-to-be-exceeded 
limits to assure safety from recognize hazards, and are clearly different from a precautionary 
limit that justifies cost-effective controls of a possible hazard. Therefore, policy makers and 
stakeholders should discuss what risks and/or monetary expenditures they consider to be de 
minimis for magnetic fields. The proposed precautionary limits are approximately three 
orders of magnitude less than the present exposure guidelines [IEEE, 2002; ACGIH, 2006; 
ICNIRP, 2010], but these relatively low levels are consistent with the TWA magnetic fields 
where cancer associations were reported by some occupational epidemiological studies 
[WHO, 2007].
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Our examples of using the benefit estimates (Tables I and VI) are based on NIOSH’s 
exposure reduction recommendations for existing workplaces, but these results can 
contribute in other ways to the development of precautionary recommendations for 
workplace MF. By obtaining estimates of an intervention’s costs, formal cost-benefit 
analyses can be performed on both changes with existing equipment and purchases of new 
equipment in order to justify investments in lower MF exposures.
Furthermore, our benefit estimates could be used to create precautionary MF control bands. 
The economic burden of MF sources can be calculated from available exposure data, and 
then grouped by the commensurate intervention (behavioral controls, engineering controls, 
shielding, etc.). The qualitative control band approach has proven useful for managing many 
occupational hazards, especially with large uncertainties on the risks [NIOSH, 2009], and 
has been applied to assuring compliance with the European Union’s standards for ELF and 
RF EMF [Bolte and Pruppers, 2006].
Such broad “rules-of-thumb” [Gigerenzer et al., 1999] are more easily understood and 
implemented than detailed cost-benefit analyses that are not always persuasive to workers 
and employers due to their mathematical complexity and large uncertainty limits. Moreover, 
cost-benefit analyses have controversial assumptions that stem from the lack of 
understanding and accounting for true long-term impacts both on the cost and benefits side 
[Ackerman, 2008]. Therefore, risk assessment experts and economists often prefer 
precautionary approach in making decisions under uncertainty [Tickner et al., 2003; 
Ackerman, 2008]. In light of the ±130% uncertainty around our ELF-MF benefit estimate, 
the decision rule in Figure 3 should not be applied rigidly to choosing an intervention, but 
instead provide an indication of the scale of justifiable expenditures.
An example of the interplay between a cost-benefit analysis and precautionary regulations 
was the 2004 ruling on new transmission lines in California. The California EMF Program 
commissioned a cost-benefit analysis of residential MF from powerlines [von Winterfeldt et 
al., 2004]. However, its recommendations were never used by the California Public Utility 
Commission. Instead they simply decreed that 4% of the costs of new transmission lines be 
used for the mitigation of EMF exposures without any supporting data [California Public 
Utility Commission, 2006]. Nonetheless, this precautionary measure on new transmission 
lines has endured as an important policy resulting from the era of the California EMF 
Program.
Whether our benefit analysis will make precautionary recommendations for workplaces 
persuasive to employers and workers will require further investigation.
CONCLUSIONS
This risk assessment was undertaken to estimate the economic benefits from reducing 
occupational exposures to power-frequency magnetic fields as guidance on precautionary 
recommendations. A 1 μT reduction in a worker’s TWA magnetic field exposure is expected 
to increase the worker’s disability-free life by an average of 0.04 years (2 weeks), which is a 
$5,100 benefit to the U.S. in year 2010 dollars. These benefits from a MF reduction might 
Bowman et al. Page 13
Am J Ind Med. Author manuscript; available in PMC 2015 December 22.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
increase by as much as 80% when exposures to mercury, arsenic, lead, pesticides, 
herbicides, or solvents also occur. Further, these reductions should be focused on TWA 
exposures exceeding a precautionary limit in a range of 0.2–0.5 μT, depending on the cancer 
risks and/or the costs of an intervention which are considered minimal.
These calculations are “evidence-based” in the sense that they are derived from publicly 
available data by widely used risk assessment methods. Where our precautionary risk 
assessment required innovations, our assumptions are stated clearly for users to evaluate, 
and the resulting mathematical formulas are derived in the Supplemental Online Material. 
Nonetheless, our findings would be more reliable if improved data on the dose–response 
parameters and the posterior probability could be produced.
These monetary benefit estimates can guide policy makers, employers and workers in 
developing precautionary approaches to managing workplace MF exposures in several ways. 
Cost-benefit analyses of possible interventions can be conducted by obtaining cost estimates 
for the exposure reduction alternatives. Alternatively, calculations of the cancer burdens can 
be used to group MF sources into control bands. In addition, a precautionary level from 
Figure 5 can be adopted to identify MF exposures that are too low to justify interventions. 
Although further work will be needed to successfully implement such strategies for 
managing possible workplace hazards, this quantitative risk assessment provides an 
objective basis for precautionary approaches.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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FIGURE 1. 
Flow chart for the risk assessment.
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FIGURE 2. 
The exponential (Eq. 1) and linear dose–response (DR) functions for brain cancer and 
leukemia compared with the cumulative magnetic field exposures (right axis) which were 
calculated from the combined electric utility studies [Kheifets et al., 1999].
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FIGURE 3. 
Decision tree based on the costs of an intervention that lowers a magnetic field exposure 
from Bbefore to Bafter, taking into account the posterior probability Pc that the reported 
cancer risks are causal.
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FIGURE 4. 
Years of life lost (YLL) from brain cancer and leukemia as a function of the time-weighted 
average (TWA) magnetic fields, showing linear regression lines through the origin.
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FIGURE 5. 
Proposed precautionary limits (PL) for the TWA magnetic field below which the expected 
value of the cancer risks (excess incidence of brain cancer plus leukemia) or the discounted 
economic burden may be considered minimal (in bold). Ninety-five percent confidence 
limits shown for selected de minimis values.
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FIGURE 6. 
The expected benefits and upper uncertainty limit from a proposed intervention [Moss and 
Booher, 1994] to move the control room for an electrosteel furnace away from the 
transformer’s magnetic fields. (The lower uncertainty limit is zero.)
Bowman et al. Page 24
Am J Ind Med. Author manuscript; available in PMC 2015 December 22.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Bowman et al. Page 25
TABLE I
Health Hazard Evaluations (HHE) of Magnetic Field (MF) Exposures Between the Threshold Limit Valuea 
and Cancer Associationsb
Site MF source
MF exposures (μT)
HHE report’s recommendationMaximum TWA
Steel plant Transformer for 
induction furnace
79.4–148.2 10.8–16.9
“… the existing level of ELFc exposure to control room personnel is 
unnecessary and could be improved by relocating either the transformer or 
control room. While it is true that present levels are below existing 
occupational standards, it is also true that very little is known about 
biological effects of ELF. While some exposure may have to be 
encountered from control room activities, it does not have to be due to 
unnecessary exposure.” [Moss and Booher, 1994]
Office Power switchboard 6.1–39.8 0.3–3.4 “… the magnetic field levels in the back area of the Tax Office are at the 
higher end of the exposure level range documented in previous NIOSH 
evaluations, and all levels were below the current occupational exposure 
ceiling limit … As with many occupational exposures, however, 
employees or employers may wish to reduce them even if they do not 
exceed current limits.” [Moss and Ragab, 1995]
TV stations Video tape eraser 
(degausser)
133.7–330.6 2.2–3.9 “The degaussing machine should be relocated to an area where fewer 
people would be exposed to its emissions. If possible, a method to 
mechanically load tape into the machine without having an operator stand 
next to it should be developed.” [Malkin and Moss, 1995]
a
Threshold limit value = 1,000 μT maximum for 60 Hz magnetic fields.
bAssociations with leukemia and brain cancer for time-weighted average (TWA) MF in categories whose lower bounds are 0.2–1 μT.
c
ELF = extremely low frequencies = 3–3,000 Hz; NIOSH, National Institute for Occupational Safety and Health.
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TABLE II
Relative Risks (RR) in the Highest Exposure Category and Dose–Response Slopes From the Comparative 
Study of Electric Utility Cohorts [Kheifets et al., 1999], Plus the Point of Transition From the Exponential 
Models to Their Linear Extensions (Fig. 2)
Cancer and magnetic field exposure Relative risk (95% CI and one-tailed P-value) Logistic-linear transition pointa
Leukemia
 Highest category ≥16 μT-yr 1.48 (0.96–2.30, P = 0.04*) 41.1 μT-yr
 Dose–response in RR/10 μT-yr 1.10 (0.98–1.23, P = 0.05)
Brain cancer
 Highest category ≥16 μT-yr 1.87 (1.17–2.98, P = 0.004*) 51.2 μT-yr
 Dose–response in RR/10 μT-yr 1.13 (0.99–1.29, P = 0.03)
*Calculated from P = 1 − N(ln RR/SE) where the standard error (SE) in ln RR is estimated in Supplemental Online Material [See Section A in the 
Supplemental Information].
aCumulative exposure at risk estimated for highest exposure category.
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TABLE V
Slopes for the Cancer and Economic Burden Metrics, Plus Their 95% Confidence Limits and Uncertainty 
Limits From Linear Regressions (Constant Term = 0)
Metric
Regression coefficienta (yr or $/worker/μT)
Without discounting With discounting
Brain cancer
 YLL 0.0431 0.0312
 YLD 0.0015 0.0014
Leukemia
 YLL 0.0390 0.0293
 YLD 0.0036 0.0035
Expected total DALY 0.052 0.039
Expected economic burdenb $6,900 $5,100
Sensitivity analysis of the expected economic burdenb with discounting:
 95% confidence limits from random errors $1,000–9,000
 Uncertainty limits with single company bias $0–7,000
  With P and DALY’s value added $0–12,000
  With mercury exposure added $0–15,000
a
R2 > 0.99 for all regressions, implying very linear overall relationship.
b
Economic burden in year 2010 U.S. dollars after factoring in inflation rate as obtained from Bureau of Labor Statistics [2011].
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